Text Size

Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT01258218
First received: December 9, 2010
Last updated: June 5, 2012
Last verified: June 2012
History of Changes
  Purpose

The intent of this study is to evaluate the performance of the implanted Accent MRI TM system in a clinical setting and optionally in the MRI environment. This system includes the St. Jude Medical Tendril MRI™ lead and SJM Accent MRITM DR pacemaker. Also the MRI Activator™ will be evaluated in this study. The MRI Activator is a handheld device that allows the user to enable and disable MRI Settings as well as check the status of MRI Settings in the pacemaker. The patient population under study includes patients with a standard bradycardia pacing indication.


Condition Intervention
Bradycardia
 Device: Implantation of an Accent MRI device

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment

Further study details as provided by St. Jude Medical:

Enrollment: 78
Study Start Date: February 2011
Study Completion Date: November 2011
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Accent MRI Group Device: Implantation of an Accent MRI device
Implantation of an Accent MRI device

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with approved Class I or Class II indication per ESC guidelines for implantation of a dual chamber pacemaker or single chamber pacemaker.

Criteria

Inclusion Criteria:

  • Approved Class I or Class II indication per ESC guidelines for implantation of a dual chamber pacemaker or single chamber pacemaker.
  • Receiving a new Accent MRITM pacemaker and Tendril MRI™ lead (either initial implant or complete system change out with no abandoned devices).
  • Ability to provide informed consent for study participation.
  • Is willing and able to comply with the prescribed follow-up tests and schedule of evaluations.

Exclusion Criteria:

  • Have an existing pacemaker or ICD (abandoned devices and/or leads are not allowed. A new pacemaker and lead or complete system change out is required for enrollment).
  • Have an existing active/inactive implanted medical device (e. g., Neurostimulator, infusion pump, etc.).
  • Have a non-MRI compatible device or material implant (e.g., intracranial aneurysm clip, non-MRI compatible devices or material, metals or alloys, etc.).
  • Have a lead extender or adaptor.
  • Have a mechanical, prosthetic or bioprosthetic tricuspid heart valve.
  • Have an abdominal diameter (approximately > 60cm) which results in contact with the magnet façade.
  • Are currently participating in a study that includes an active treatment arm.
  • Are pregnant or planning to become pregnant during the duration of the study.
  • Have a life expectancy of less than 6 months due to any condition.
  • Are less than 18 years of age.
  • Are unable to comply with the follow up schedule.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01258218

Locations
Austria
Graz, Austria
Sponsors and Collaborators
St. Jude Medical
  More Information

No publications provided

Responsible Party: St. Jude Medical
ClinicalTrials.gov Identifier: NCT01258218     History of Changes
Other Study ID Numbers: CR-10-027-EU-LV
Study First Received: December 9, 2010
Last Updated: June 5, 2012
Health Authority: Netherlands: Medical Ethics Review Committee (METC)

Additional relevant MeSH terms:
Bradycardia
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 22, 2013